BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7606739)

  • 1. A gene for susceptibility to small intestinal cancer, ssic1, maps to the distal part of mouse chromosome 4.
    Fijneman RJ; Demant P
    Cancer Res; 1995 Jul; 55(14):3179-82. PubMed ID: 7606739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of mouse major histocompatibility complex (H-2) on N-ethyl-N-nitrosourea-induced tumor formation in various organs.
    Oomen LC; van der Valk MA; Hart AA; Demant P; Emmelot P
    Cancer Res; 1988 Dec; 48(23):6634-41. PubMed ID: 3180072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethylnitrosourea-induced development of malignant schwannomas in the rat: two distinct loci on chromosome of 10 involved in tumor susceptibility and oncogenesis.
    Kindler-Röhrborn A; Kölsch BU; Fischer C; Held S; Rajewsky MF
    Cancer Res; 1999 Mar; 59(5):1109-14. PubMed ID: 10070970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complex interactions of new quantitative trait loci, Sluc1, Sluc2, Sluc3, and Sluc4, that influence the susceptibility to lung cancer in the mouse.
    Fijneman RJ; de Vries SS; Jansen RC; Demant P
    Nat Genet; 1996 Dec; 14(4):465-7. PubMed ID: 8944028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A locus that influences susceptibility to 1, 2-dimethylhydrazine-induced colon tumors maps to the distal end of mouse chromosome 3.
    Angel JM; Popova N; Lanko N; Turusov VS; DiGiovanni J
    Mol Carcinog; 2000 Jan; 27(1):47-54. PubMed ID: 10642436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposite effects of modifiers of the ApcMin mutation in intestine and mammary gland.
    Czarnomska A; Krysiak E; Piskorowska J; Sitarz M; Pysniak K; Pilcík T; Demant P
    Cancer Res; 2003 Aug; 63(15):4533-7. PubMed ID: 12907628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of nucleotide excision repair deficiency in intestinal tumorigenesis in multiple intestinal neoplasia (Min) mice.
    Steffensen IL; Schut HA; Nesland JM; Tanaka K; Alexander J
    Mutat Res; 2006 Dec; 611(1-2):71-82. PubMed ID: 16962818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinants in the H-2S/H-2D interval of mouse chromosome 17 define the map position of a gene for cleft palate susceptibility.
    Gasser DL; Yadvish KN; Trammell MA; Goldman AS
    Teratology; 1988 Dec; 38(6):571-7. PubMed ID: 3238613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal tumorigenesis in multiple intestinal neoplasia mice induced by the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine: perinatal susceptibility, regional variation, and correlation with DNA adducts.
    Steffensen IL; Schut HA; Paulsen JE; Andreassen A; Alexander J
    Cancer Res; 2001 Dec; 61(24):8689-96. PubMed ID: 11751386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of novel genetic loci contributing to 12-O-tetradecanoylphorbol-13-acetate skin tumor promotion susceptibility in DBA/2 and C57BL/6 mice.
    Angel JM; Caballero M; DiGiovanni J
    Cancer Res; 2003 Jun; 63(11):2747-51. PubMed ID: 12782578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple lupus susceptibility loci map to chromosome 1 in BXSB mice.
    Hogarth MB; Slingsby JH; Allen PJ; Thompson EM; Chandler P; Davies KA; Simpson E; Morley BJ; Walport MJ
    J Immunol; 1998 Sep; 161(6):2753-61. PubMed ID: 9743333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new type of genetic regulation of allogeneic response. A novel locus on mouse chromosome 4, Alan2 controls MLC reactivity to three different alloantigens: C57BL/10, BALB/c and CBA.
    Havelková H; Badalová J; Demant P; Lipoldová M
    Genes Immun; 2000 Dec; 1(8):483-7. PubMed ID: 11197689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic analysis of three-dimensional shape of mouse lung tumors reveals eight lung tumor shape-determining (Ltsd) loci that are associated with tumor heterogeneity and symmetry.
    Tripodis N; Demant P
    Cancer Res; 2003 Jan; 63(1):125-31. PubMed ID: 12517788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of genetic background on spontaneous or 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced intestinal tumorigenesis in Min/+ mice.
    Steffensen IL; Alexander J
    Cancer Lett; 2006 Aug; 240(2):289-96. PubMed ID: 16343741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of the Pas1 and Par2 genes in determination of the unique, intermediate susceptibility of BALB/cByJ mice to urethane-induction of lung carcinogenesis: differential effects on tumor multiplicity, size and Kras2 mutations.
    Karasaki H; Obata M; Ogawa K; Lee GH
    Oncogene; 1997 Oct; 15(15):1833-40. PubMed ID: 9362450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatic mutational mechanisms involved in intestinal tumor formation in Min mice.
    Shoemaker AR; Luongo C; Moser AR; Marton LJ; Dove WF
    Cancer Res; 1997 May; 57(10):1999-2006. PubMed ID: 9157997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fine chromosomal localization of the mouse Par2 gene that confers resistance against urethane-induction of pulmonary adenomas.
    Lee GH; Matsushita H; Kitagawa T
    Oncogene; 2001 Jul; 20(30):3979-85. PubMed ID: 11494126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collagen-induced arthritis and TCRs in SWR and B10.Q mice expressing an Ek alpha transgene.
    Griffiths MM; Nabozny GH; Hanson J; Harper DS; McCall S; Moder KG; Cannon GW; Luthra HS; David CS
    J Immunol; 1994 Sep; 153(6):2758-68. PubMed ID: 8077680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos.
    Jacoby RF; Cole CE; Tutsch K; Newton MA; Kelloff G; Hawk ET; Lubet RA
    Cancer Res; 2000 Apr; 60(7):1864-70. PubMed ID: 10766173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoid hormone effect on transplacental carcinogenesis and lung differentiation: influence of histocompatibility-2 complex.
    Oomen LC; van der Valk MA; Hart AA; Demant P
    J Natl Cancer Inst; 1989 Apr; 81(7):512-7. PubMed ID: 2921775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.